HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Bronchogen |
|---|---|
| Class | Longevity, cognitive & bioregulators |
| Molecular formula | C18H30N4O9 |
| Molecular weight | 446.5 g/mol |
| Sequence | H-Ala-Glu-Asp-Leu-OH |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 98% by HPLC |
| Vial formats | 20mg |
| Documentation | COA + HPLC + MS, batch lot file where available |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; brief room-temperature transit is tolerated. After reconstitution (bacteriostatic water recommended), store at 2-8°C and use within the validated stability window. Avoid repeated freeze-thaw cycles. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Bronchogen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Leu / AEDL) from the Khavinson short-peptide program, studied for its effects on bronchial and pulmonary tissue in preclinical research.
Documentation
COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Bronchogen reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Bronchogen is supplied as a sterile-filtered, lyophilized white powder in 20 mg vials sealed under inert conditions. The minimum order quantity is 50 vials; larger bulk quantities and boxed kit configurations are available on request.
Every batch is released with a Certificate of Analysis reporting HPLC purity and identity confirmation by mass spectrometry (MS). Supplementary reports such as water content, residual solvents, or independent third-party testing can be provided on request for qualified B2B accounts.
No CAS Registry Number is currently assigned to Bronchogen. It is identified by its tetrapeptide sequence (Ala-Glu-Asp-Leu), molecular formula C18H30N4O9, and molecular weight of approximately 446.5 g/mol, and we confirm identity per batch by MS rather than by CAS.
Yes. We offer OEM and private-label services including custom fill weights, vial labeling, boxed kits, and branded documentation. Artwork requirements, lead times, and specifications are confirmed at the quotation stage.
No. Bronchogen is supplied strictly as a research-use-only reference material for laboratory and manufacturing customers. It is not a medicine, supplement, or food, and Pepti provides no dosing or clinical guidance. Buyers are responsible for regulatory compliance in their destination market.
Related compounds